Article
Aneugenic activity of Op18/stathmin is potentiated by the somatic Q18-->e mutation in leukemic cells.
Molecular biology of the cell - 1 Jul 2006
Holmfeldt Per, Brännström Kristoffer, Stenmark Sonja, Gullberg Martin
Abstract excerpt
Op18/stathmin (Op18) is a phosphorylation-regulated microtubule destabilizer that is frequently overexpressed in tumors. The importance of Op18 in malignancy was recently suggested by identification of a somatic Q18-->E mutation of Op18 in an adenocarcinoma. We addressed the functional consequences of aberrant Op18 expression in leukemias by analyzing the cell cycle of K562 cells either depleted of Op18 by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
